{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:31:38Z","timestamp":1774989098095,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf02253530","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T21:48:21Z","timestamp":1132696101000},"page":"415-422","source":"Crossref","is-referenced-by-count":46,"title":["Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero"],"prefix":"10.1007","volume":"111","author":[{"given":"James R.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Jenck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willy E.","family":"Haefely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02253530_CR1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003495-199142060-00010","volume":"42","author":"RN Brogden","year":"1991","unstructured":"Brogden RN, Goa KL (1991) Flumazenil: a reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist. Drugs 42:1061\u20131089","journal-title":"Drugs"},{"key":"BF02253530_CR2","first-page":"53S","volume":"29","author":"A Delini-Stula","year":"1991","unstructured":"Delini-Stula A (1991) Prospective use of partial benzodiazepine agonists in the treatment of schizophrenia. Biol Psychiatry 29:53S-54S","journal-title":"Biol Psychiatry"},{"key":"BF02253530_CR3","first-page":"1113","volume":"261","author":"M Facklam","year":"1992","unstructured":"Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE (1992) Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J Pharmacol Exp Ther 261:1113\u20131121","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253530_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430120102","volume":"12","author":"CR Gardner","year":"1988","unstructured":"Gardner CR (1988) Pharmacological profiles in vivo of benzodiazepine receptor ligands. Drug Dev Res 12:1\u201328","journal-title":"Drug Dev Res"},{"key":"BF02253530_CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0024-3205(85)90505-3","volume":"377","author":"NE Goeders","year":"1985","unstructured":"Goeders NE, Kuhar MJ (1985) Benzodiazepine receptor binding in vivo with3H-Ro 15-1788. Life Sci 377:345\u2013355","journal-title":"Life Sci"},{"issue":"Suppl. 1","key":"BF02253530_CR6","first-page":"670","volume":"7","author":"W Haefely","year":"1984","unstructured":"Haefely W (1984) Pharmacological profile of two benzodiazepine partial agonists: Ro 16-6028 and Ro 17-1812. Clin Neuropharmacol 7 [Suppl. 1]:670\u2013671","journal-title":"Clin Neuropharmacol"},{"key":"BF02253530_CR7","first-page":"165","volume-title":"Handbook of anxiety: the neurobiology of anxiety, vol 3","author":"WE Haefely","year":"1990","unstructured":"Haefely WE (1990) The GABAA-benzodiazepine receptor: biology and pharmacology. In: Burrows GD, Roth M, Noyes Jr R (eds) Handbook of anxiety: the neurobiology of anxiety, vol 3. Elsevier Amsterdam, pp 165\u2013188"},{"key":"BF02253530_CR8","first-page":"252","volume":"11","author":"W Haefely","year":"1990","unstructured":"Haefely W, Martin JR, Schoch P (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. TIPS 11:252\u2013256","journal-title":"TIPS"},{"key":"BF02253530_CR9","first-page":"379","volume-title":"GABAergic synaptic transmission","author":"W Haefely","year":"1992","unstructured":"Haefely W, Facklam M, Schoch P, Martin JR, Bonetti EP, Moreau JL, Jenck F, Richards JG (1992) Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders. In: Biggio G, Concas A, Costa E (eds) GABAergic synaptic transmission. Raven Press, New York, pp 379\u2013394"},{"key":"BF02253530_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(88)90788-1","volume":"147","author":"JRM Haigh","year":"1988","unstructured":"Haigh JRM, Feely M (1988) Ro 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice. Eur J Pharmacol 147:283\u2013285","journal-title":"Eur J Pharmacol"},{"key":"BF02253530_CR11","first-page":"167","volume-title":"Biologische Psychiatrie","author":"H Katschnig","year":"1989","unstructured":"Katschnig H, Merz WA, Nutzinger D, Alf C, Berger SP, Kutzer M (1989) Attackenweise Behandlung des Paniksyndroms mit dem partiellen Benzodiazepin-Agonisten Ro 16-6028: Resultate einer plazebo-kontrollierten Doppelblindstudie mit 24 Patienten. In: Saletu B (ed) Biologische Psychiatrie. Thieme, Stuttgart, pp 167\u2013169"},{"key":"BF02253530_CR12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-2007-1021947","volume":"21","author":"JR Martin","year":"1988","unstructured":"Martin JR, Pieri L, Bonetti EP, Schaffner R, Burkard WP, Cumin R, Haefely WE (1988) Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry 21:360\u2013362","journal-title":"Pharmacopsychiatry"},{"key":"BF02253530_CR13","first-page":"1104","volume":"16","author":"JR Martin","year":"1990","unstructured":"Martin JR, Kuwahara A, Horii I, Moreau JL, Jenck F, Sepinwall J, Haefely WE (1990) Evidence that the benzodiazepine receptor partial agonist Ro 16-6028 has minimal abuse and physical dependence liability. Soc Neurosci Abstr 16:1104","journal-title":"Soc Neurosci Abstr"},{"key":"BF02253530_CR14","first-page":"727","volume-title":"Biological psychiatry, vol 1","author":"WA Merz","year":"1991","unstructured":"Merz WA (1991) Partial benzodiazepine agonists: New concepts in the treatment of panic disorder and schizophrenia. In: Racagni G, Brunello N, Fukuda T (eds) Biological psychiatry, vol 1. Elsevier, Amsterdam, pp 727\u2013731"},{"issue":"Suppl","key":"BF02253530_CR15","first-page":"42","volume":"82","author":"M Mikkelsen","year":"1990","unstructured":"Mikkelsen M, Gulliksen G, Dam M, Vesterager A, Gram L, Schou C, Alving J (1990) Antiepileptic activity of flumazenil. Acta Neurol Scand 82 [Suppl]:42","journal-title":"Acta Neurol Scand"},{"key":"BF02253530_CR16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(90)94138-N","volume":"190","author":"JL Moreau","year":"1990","unstructured":"Moreau JL, Jenck F, Pieri L, Schoch P, Martin JR, Haefely WE (1990) Physical dependence induced in DBA\/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028. Eur J Pharmacol 190:269\u2013273","journal-title":"Eur J Pharmacol"},{"key":"BF02253530_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ddr.430220409","volume":"22","author":"JL Moreau","year":"1991","unstructured":"Moreau JL, Jenck F, Bonetti EP, Martin JR, Haefely WE (1991) Novel long-acting benzodiazepine receptor ligands Ro 41-7812 and Ro 42-8773: neurological and behavioral profile. Drug Dev Res 22:375\u2013383","journal-title":"Drug Dev Res"},{"key":"BF02253530_CR18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1358\/dof.1988.013.08.63039","volume":"13","author":"L Pieri","year":"1988","unstructured":"Pieri L, Hunkeler W, Jauch R, Merz WA, Roncari G, Timm U (1988) Ro 16-6028, a benzodiazepine receptor partial agonist. Drugs of the Future 13:730\u2013735","journal-title":"Drugs of the Future"},{"key":"BF02253530_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0140-6736(91)90799-U","volume":"337","author":"I Savic","year":"1991","unstructured":"Savic I, Widen L, Stone-Elander S (1991) Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337:133\u2013137","journal-title":"Lancet"},{"key":"BF02253530_CR20","first-page":"709","volume-title":"Biological psychiatry, vol 1","author":"EM Sellers","year":"1991","unstructured":"Sellers EM, Busto U, Kaplan HL (1991) Clinical abuse liability of partial and full agonist benzodiazepines: a comparison of bretazenil, diazepam and alprazolam. In: Racagni G, Brunello N, Fukuda T (eds) Biological psychiatry, vol 1. Elsevier, Amsterdam, pp 709\u2013712"},{"key":"BF02253530_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(91)90124-8","volume":"36","author":"SW Woods","year":"1991","unstructured":"Woods SW, Charney DS, Silver JM, Krystal JH, Heninger GR (1991) Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder. Psychiatry Res 36:115\u2013127","journal-title":"Psychiatry Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02253530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02253530\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02253530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T14:52:25Z","timestamp":1558018345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02253530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF02253530"],"URL":"https:\/\/doi.org\/10.1007\/bf02253530","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}